Relapsing Fever Borrelia Species by PCR
Also known as: RFBPCR
Use
The test is used to diagnose relapsing fever caused by various Borrelia species during the symptomatic phase of infection. It detects nucleic acid from species like B. hermsii, B. miyamotoi, B. parkeri, and B. turicatae. Additional less frequent species such as B. recurrentis, B. coriaceae, B. theileri, B. lonestari, and B. anserina may also be detected, indicating its broad applicability for relapsing fever diagnosis.
Special Instructions
Specimen source is required for this test. The test has been approved by New York state. Unacceptable specimen conditions include serum, plasma, and heparinized specimens.
Limitations
The test is designed to detect but not differentiate among different Borrelia species. A negative result does not rule out the presence of PCR inhibitors or low concentration of the target nucleic acid. It has not been cleared or approved by the FDA.
New York Approved
Methodology
PCR-based (PCR)
Biomarkers
LOINC Codes
- 31208-2
- 96056-7
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
1 mL
Minimum Volume
0.5 mL
Container
Lavender (K2EDTA) or Pink (K2EDTA)
Storage Instructions
Refrigerated
Causes for Rejection
Serum or plasma. Heparinized specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 24 hours |
| Refrigerated | 5 days |
| Frozen | 1 week |
Other tests from different labs that may be relevant